Stroke:视网膜中央动脉阻塞后房颤的检出率

2021-06-09 MedSci原创 MedSci原创

CRAO后AF的检出率高于年龄、性别和合并症匹配的对照者,与缺血性脑卒中后AF的检出率相当。阵发性AF应被认为是CRAO的一种病因,这些患者可能受益于长期的心脏监测。

视网膜中央动脉阻塞(CRAO)会导致突然的、不可逆的失明,是急性缺血性卒中的一种形式。

近日,血管疾病领域权威杂志Stroke上发表了一篇研究文章,在该研究中,研究人员试图明确CRAO后通过扩展心脏监测检测到房颤(AF)患者的比例。

研究人员进行了一项回顾性、观察性队列研究,数据来自3080万人的电子健康记录,与Medtronic CareLink数据库中270万人次的心脏监测设备的数据进行了交叉引用。研究人员将患者分为3组:(1)CRAO、(2)脑缺血性卒中和(3)年龄、性别和合并症匹配的对照组。该研究的主要终点是新检测到的AF(定义为在心脏监测装置上检测2分钟以上的AF)。

CRAO后AF的检出率

研究人员回顾了两个数据库中共同的884 431例患者记录,确定了100例CRAO患者,6559例缺血性卒中患者和1000例匹配的对照者。CRAO术后2年累计新AF发生率为49.6% (95%CI为37.4%-61.7%)。CRAO患者的AF发生率高于对照组(风险比为1.64 [95%CI为1.17-2.31]),与卒中患者的房颤发生率相当(风险比为1.01 [95%CI为0.75-1.36])。与匹配的对照组相比,CRAO与更高的新发卒中发生率相关(风险比为2.85[95%CI为1.29-6.29])。

由此可见,CRAO后AF的检出率高于年龄、性别和合并症匹配的对照者,与缺血性脑卒中后AF的检出率相当。阵发性AF应被认为是CRAO的一种病因,这些患者可能受益于长期的心脏监测。

原始出处:

Brian Mac Grory.et al.Detection of Atrial Fibrillation After Central Retinal Artery Occlusion.stroke.2021.https://doi.org/10.1161/STROKEAHA.120.033934

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1696977, encodeId=877a16969e716, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Feb 28 16:29:51 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777008, encodeId=e2bf1e7700850, content=<a href='/topic/show?id=97532206ed9' target=_blank style='color:#2F92EE;'>#中央动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22067, encryptionId=97532206ed9, topicName=中央动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aa139073856, createdName=yykkxiaodou, createdTime=Fri Oct 15 09:29:51 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904820, encodeId=35961904820ce, content=<a href='/topic/show?id=ae97625036d' target=_blank style='color:#2F92EE;'>#检出率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62503, encryptionId=ae97625036d, topicName=检出率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Sep 21 06:29:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270281, encodeId=2f3e12e0281a3, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573195, encodeId=f8a215e31955d, content=<a href='/topic/show?id=21c890e37f5' target=_blank style='color:#2F92EE;'>#视网膜中央动脉阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90737, encryptionId=21c890e37f5, topicName=视网膜中央动脉阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a29b15833374, createdName=zxxiang, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1031407, encodeId=09b4103140efa, content=房颤,临床上碰到很多哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=心介, createdTime=Thu Jun 10 01:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972312, encodeId=26209e2312ca, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210609/e131133cd6ab4619acc1f20c84783bbf/62b71e50bccc4897884c0a631acb4b80.jpg, createdBy=f9f65518012, createdName=大大大chuan, createdTime=Wed Jun 09 22:41:45 CST 2021, time=2021-06-09, status=1, ipAttribution=)]
    2022-02-28 tomyang96
  2. [GetPortalCommentsPageByObjectIdResponse(id=1696977, encodeId=877a16969e716, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Feb 28 16:29:51 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777008, encodeId=e2bf1e7700850, content=<a href='/topic/show?id=97532206ed9' target=_blank style='color:#2F92EE;'>#中央动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22067, encryptionId=97532206ed9, topicName=中央动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aa139073856, createdName=yykkxiaodou, createdTime=Fri Oct 15 09:29:51 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904820, encodeId=35961904820ce, content=<a href='/topic/show?id=ae97625036d' target=_blank style='color:#2F92EE;'>#检出率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62503, encryptionId=ae97625036d, topicName=检出率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Sep 21 06:29:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270281, encodeId=2f3e12e0281a3, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573195, encodeId=f8a215e31955d, content=<a href='/topic/show?id=21c890e37f5' target=_blank style='color:#2F92EE;'>#视网膜中央动脉阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90737, encryptionId=21c890e37f5, topicName=视网膜中央动脉阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a29b15833374, createdName=zxxiang, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1031407, encodeId=09b4103140efa, content=房颤,临床上碰到很多哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=心介, createdTime=Thu Jun 10 01:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972312, encodeId=26209e2312ca, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210609/e131133cd6ab4619acc1f20c84783bbf/62b71e50bccc4897884c0a631acb4b80.jpg, createdBy=f9f65518012, createdName=大大大chuan, createdTime=Wed Jun 09 22:41:45 CST 2021, time=2021-06-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1696977, encodeId=877a16969e716, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Feb 28 16:29:51 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777008, encodeId=e2bf1e7700850, content=<a href='/topic/show?id=97532206ed9' target=_blank style='color:#2F92EE;'>#中央动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22067, encryptionId=97532206ed9, topicName=中央动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aa139073856, createdName=yykkxiaodou, createdTime=Fri Oct 15 09:29:51 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904820, encodeId=35961904820ce, content=<a href='/topic/show?id=ae97625036d' target=_blank style='color:#2F92EE;'>#检出率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62503, encryptionId=ae97625036d, topicName=检出率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Sep 21 06:29:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270281, encodeId=2f3e12e0281a3, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573195, encodeId=f8a215e31955d, content=<a href='/topic/show?id=21c890e37f5' target=_blank style='color:#2F92EE;'>#视网膜中央动脉阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90737, encryptionId=21c890e37f5, topicName=视网膜中央动脉阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a29b15833374, createdName=zxxiang, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1031407, encodeId=09b4103140efa, content=房颤,临床上碰到很多哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=心介, createdTime=Thu Jun 10 01:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972312, encodeId=26209e2312ca, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210609/e131133cd6ab4619acc1f20c84783bbf/62b71e50bccc4897884c0a631acb4b80.jpg, createdBy=f9f65518012, createdName=大大大chuan, createdTime=Wed Jun 09 22:41:45 CST 2021, time=2021-06-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1696977, encodeId=877a16969e716, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Feb 28 16:29:51 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777008, encodeId=e2bf1e7700850, content=<a href='/topic/show?id=97532206ed9' target=_blank style='color:#2F92EE;'>#中央动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22067, encryptionId=97532206ed9, topicName=中央动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aa139073856, createdName=yykkxiaodou, createdTime=Fri Oct 15 09:29:51 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904820, encodeId=35961904820ce, content=<a href='/topic/show?id=ae97625036d' target=_blank style='color:#2F92EE;'>#检出率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62503, encryptionId=ae97625036d, topicName=检出率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Sep 21 06:29:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270281, encodeId=2f3e12e0281a3, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573195, encodeId=f8a215e31955d, content=<a href='/topic/show?id=21c890e37f5' target=_blank style='color:#2F92EE;'>#视网膜中央动脉阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90737, encryptionId=21c890e37f5, topicName=视网膜中央动脉阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a29b15833374, createdName=zxxiang, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1031407, encodeId=09b4103140efa, content=房颤,临床上碰到很多哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=心介, createdTime=Thu Jun 10 01:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972312, encodeId=26209e2312ca, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210609/e131133cd6ab4619acc1f20c84783bbf/62b71e50bccc4897884c0a631acb4b80.jpg, createdBy=f9f65518012, createdName=大大大chuan, createdTime=Wed Jun 09 22:41:45 CST 2021, time=2021-06-09, status=1, ipAttribution=)]
    2021-06-11 zutt
  5. [GetPortalCommentsPageByObjectIdResponse(id=1696977, encodeId=877a16969e716, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Feb 28 16:29:51 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777008, encodeId=e2bf1e7700850, content=<a href='/topic/show?id=97532206ed9' target=_blank style='color:#2F92EE;'>#中央动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22067, encryptionId=97532206ed9, topicName=中央动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aa139073856, createdName=yykkxiaodou, createdTime=Fri Oct 15 09:29:51 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904820, encodeId=35961904820ce, content=<a href='/topic/show?id=ae97625036d' target=_blank style='color:#2F92EE;'>#检出率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62503, encryptionId=ae97625036d, topicName=检出率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Sep 21 06:29:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270281, encodeId=2f3e12e0281a3, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573195, encodeId=f8a215e31955d, content=<a href='/topic/show?id=21c890e37f5' target=_blank style='color:#2F92EE;'>#视网膜中央动脉阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90737, encryptionId=21c890e37f5, topicName=视网膜中央动脉阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a29b15833374, createdName=zxxiang, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1031407, encodeId=09b4103140efa, content=房颤,临床上碰到很多哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=心介, createdTime=Thu Jun 10 01:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972312, encodeId=26209e2312ca, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210609/e131133cd6ab4619acc1f20c84783bbf/62b71e50bccc4897884c0a631acb4b80.jpg, createdBy=f9f65518012, createdName=大大大chuan, createdTime=Wed Jun 09 22:41:45 CST 2021, time=2021-06-09, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1696977, encodeId=877a16969e716, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Feb 28 16:29:51 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777008, encodeId=e2bf1e7700850, content=<a href='/topic/show?id=97532206ed9' target=_blank style='color:#2F92EE;'>#中央动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22067, encryptionId=97532206ed9, topicName=中央动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aa139073856, createdName=yykkxiaodou, createdTime=Fri Oct 15 09:29:51 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904820, encodeId=35961904820ce, content=<a href='/topic/show?id=ae97625036d' target=_blank style='color:#2F92EE;'>#检出率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62503, encryptionId=ae97625036d, topicName=检出率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Sep 21 06:29:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270281, encodeId=2f3e12e0281a3, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573195, encodeId=f8a215e31955d, content=<a href='/topic/show?id=21c890e37f5' target=_blank style='color:#2F92EE;'>#视网膜中央动脉阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90737, encryptionId=21c890e37f5, topicName=视网膜中央动脉阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a29b15833374, createdName=zxxiang, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1031407, encodeId=09b4103140efa, content=房颤,临床上碰到很多哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=心介, createdTime=Thu Jun 10 01:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972312, encodeId=26209e2312ca, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210609/e131133cd6ab4619acc1f20c84783bbf/62b71e50bccc4897884c0a631acb4b80.jpg, createdBy=f9f65518012, createdName=大大大chuan, createdTime=Wed Jun 09 22:41:45 CST 2021, time=2021-06-09, status=1, ipAttribution=)]
    2021-06-10 心介

    房颤,临床上碰到很多哦

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1696977, encodeId=877a16969e716, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Feb 28 16:29:51 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777008, encodeId=e2bf1e7700850, content=<a href='/topic/show?id=97532206ed9' target=_blank style='color:#2F92EE;'>#中央动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22067, encryptionId=97532206ed9, topicName=中央动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aa139073856, createdName=yykkxiaodou, createdTime=Fri Oct 15 09:29:51 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904820, encodeId=35961904820ce, content=<a href='/topic/show?id=ae97625036d' target=_blank style='color:#2F92EE;'>#检出率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62503, encryptionId=ae97625036d, topicName=检出率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Tue Sep 21 06:29:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270281, encodeId=2f3e12e0281a3, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573195, encodeId=f8a215e31955d, content=<a href='/topic/show?id=21c890e37f5' target=_blank style='color:#2F92EE;'>#视网膜中央动脉阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90737, encryptionId=21c890e37f5, topicName=视网膜中央动脉阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a29b15833374, createdName=zxxiang, createdTime=Fri Jun 11 13:29:51 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1031407, encodeId=09b4103140efa, content=房颤,临床上碰到很多哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=心介, createdTime=Thu Jun 10 01:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972312, encodeId=26209e2312ca, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210609/e131133cd6ab4619acc1f20c84783bbf/62b71e50bccc4897884c0a631acb4b80.jpg, createdBy=f9f65518012, createdName=大大大chuan, createdTime=Wed Jun 09 22:41:45 CST 2021, time=2021-06-09, status=1, ipAttribution=)]
    2021-06-09 大大大chuan

    1

    0

相关资讯

JAMA:植入式循环监护大大提高了大血管或小血管疾病中风患者的房颤检出率

对于大血管或小血管疾病导致的中风患者,其12个月的房颤发生率高于先前的认识,植入式循环监护大大提高了房颤检出率,未来需要进一步的研究以识别额外的房颤事件是否具有临床意义。

ACC.21|LAAOS III:左心耳封堵预防房颤相关卒中再添新证北医三院唐熠达教授团队:

左心耳是房颤患者血栓形成主要部位。左心耳封堵(LAAO)是否可降低房颤患者的卒中风险是业界的重要假说之一,但一直未被有力证据正证实。近期以Whitlock RP为首的心外科及房颤领域专家共同进行了LA

JAHA:房颤患者导管消融的相关并发症

该研究的数据显示,房颤患者CA术后并发症的发生率随年龄增长而增加。

JAMA:长期植入式心电图监测对新近缺血性中风患者房颤检出率的影响

对于新近发生缺血性中风但既往无房颤证据的患者,植入式心电图监测12个月相比于常规的30天外循环监测,房颤检出率显著提高,未来需要进一步的研究来考察长期植入式心电图监测的临床结果和成本效益。

JACC:非奈利酮可有效降低糖尿病合并慢性肾病患者的房颤发生率

在CKD合并T2D的患者中,非奈利酮治疗降低了新发AFF的风险,无论基线时有无AFF病史